Albert N. Marchio's most recent trade in Fresh Tracks Therapeutics Inc was a trade of 1,250 Restricted Stock Units done . Disclosure was reported to the exchange on Dec. 28, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fresh Tracks Therapeutics Inc | N. Albert Marchio | Director, CEO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Dec 2023 | 1,250 | 0 | - | - | Restricted Stock Units | |
| Fresh Tracks Therapeutics Inc | Albert N. Marchio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 1,250 | 1,250 | - | - | Restricted Stock Units | |
| Fresh Tracks Therapeutics Inc | Albert N. Marchio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Fresh Tracks Therapeutics Inc | Albert N. Marchio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |